Jingmiao Shi

Title: Inventor Jingmiao Shi: Innovating Anti-Tumor Drug Development

Introduction: Jingmiao Shi, based in Nanjing, China, is an accomplished inventor who holds a patent that contributes significantly to the field of pharmaceutical technology. With a focus on innovative compounds, his work is designed to aid in the treatment and prevention of various diseases associated with mutant epidermal growth factor receptors.

Latest Patents: Jingmiao Shi is recognized for his patent on "Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof." This invention pertains to a type of deuterated derivatives that can either be utilized as compounds of Formula (I) or their pharmaceutically acceptable salts. These derivatives have shown potential for inhibiting the growth of various tumor cells, proving effective in the development of anti-tumor drugs by targeting specific mutant forms of epidermal growth factor receptors and inhibiting related proteases.

Career Highlights: Jingmiao currently works with Nanjing Chuangte Pharmaceutical Technology Co., Ltd., where he continues to advance his research and innovations in the pharmaceutical field. His dedication to drug development and targeting tumor growth reflects his significant contributions to medical science.

Collaborations: Throughout his career, Jingmiao has collaborated with esteemed colleagues such as Yongqiang Zhu and Zhaogang Liu. Together, they work on various projects aimed at enhancing the effectiveness of treatments within the realm of oncology.

Conclusion: Jingmiao Shi stands out as an inventor committed to improving healthcare through innovative drug development. His patented work not only showcases his expertise in pharmaceuticals but also highlights the collaborative spirit present in the pursuit of better treatment options for patients facing challenging health conditions. With ongoing contributions to the field, Shi's work holds promise for future advancements in anti-tumor therapies.